Three Hungarian Mangalica pigs named Zoya, Masha, and Tanya took their first wobbly steps just 60 days after their spinal cords were completely severed — a milestone that stunned even the scientists who treated them. At the Sklifosovsky Institute for Emergency Medicine in Moscow, a team led by Dr. Michael Lebenstein-Gumovski achieved what was once considered impossible: restoring walking ability in animals with fully transected spinal cords. Using an experimental gel made from polyethylene glycol and chitosan, the researchers bridged the gap between severed nerve ends, enabling rapid functional recovery in the pigs. This breakthrough offers a radical new vision for treating spinal injuries — not through slow regeneration, but through immediate repair.
Spinal cord injuries in humans and other mammals have long been considered permanent because damaged axons fail to regrow, and scar tissue blocks signal transmission. But nature offers clues: primitive organisms like roundworms can naturally fuse broken nerves. Inspired by this, Lebenstein-Gumovski’s team developed a fusogen-based gel designed to mimic that process. When applied to the injury site, the gel acts as a molecular welder, sealing and reconnecting nerve membranes. In the study, five female pigs underwent complete spinal cord transection under anesthesia. Three received the gel plus spinal stabilization with screws and rods; two control pigs received stabilization only.
The difference was dramatic. Within two days, the treated pigs responded to skin pricks, signaling a return of sensation. By day five, all three had regained full bladder control — a critical marker of neurological recovery often lost after severe spinal injury. By the two-month mark, each was standing and walking with all four limbs. In contrast, the untreated pigs showed no sensory or motor recovery. Microscopic analysis revealed why: the control group developed dense scars and fluid-filled cysts, while the treated animals showed nerve fibers actively crossing the injury site.
The speed of recovery is what sets this study apart. As the researchers write, the improvements “cannot be attributed solely to axonal regeneration,” pointing instead to immediate axonal fusion as the driving force. This suggests a new therapeutic window — one where repair happens in days, not years. While human trials are still distant and larger studies are needed, the implications are profound. Millions of people worldwide live with paralysis due to spinal cord injuries, and current treatments offer limited hope. This gel, if proven safe and effective in future research, could one day change that.
The journey from pig to person is long, but the path now seems less like a dead end and more like a bridge — one built from science, persistence, and the quiet steps of three pigs who walked again.